Company news

CervoMed Inc. news in 2023

CervoMed Inc.'s news releases, calls and decks from 2023, newest first.

View company

CervoMed Reports Third Quarter 2023 Financial Results and Business Highlights

November 12, 2023

CervoMed Announces Oral Presentation at CTAD 2023 Highlighting Learnings from Phase 2a Which Optimized the Design of the Phase 2b Clinical Study of Neflamapimod in Dementia with Lewy Bodies

October 24, 2023

CervoMed Announces Publications in Major Peer-Reviewed Journals That Inform on Potential of Neflamapimod as a Disease-Modifying Therapy for the Major Dementias

October 23, 2023

CervoMed Announces Oral Presentation at CTAD 2023 Highlighting Phase 2b Neflamapimod Program for the Treatment of Patients with Dementia with Lewy Bodies

October 17, 2023

Decks in 2023